13D/13G Filings - AbbVie Biotechnology Ltd.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-25
4:15 pm
Sale
2025-03-31 13G Carisma Therapeutics, Inc.
CARM
AbbVie Biotechnology Ltd. 1,855,871
4.400%
-893,984decrease
(-32.51%)
Filing
History
2024-03-13
4:30 pm
Purchase
2023-12-31 13G Carisma Therapeutics, Inc.
CARM
AbbVie Biotechnology Ltd. 2,749,855
6.800%
2,749,855increase
(New Position)
Filing
History